Velan Capital Investment Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.5M Hold
6,986,744
14.29% 1
2025
Q1
$15.4M Hold
6,986,744
15.81% 1
2024
Q4
$10.7M Hold
6,986,744
9.22% 3
2024
Q3
$13.9M Hold
6,986,744
13% 3
2024
Q2
$24.5M Hold
6,986,744
14.01% 3
2024
Q1
$19.4M Hold
6,986,744
8.79% 4
2023
Q4
$11.9M Hold
6,986,744
6.93% 2
2023
Q3
$7.2M Buy
6,986,744
+2,486,744
+55% +$2.56M 5.8% 4
2023
Q2
$5.22M Hold
4,500,000
4.85% 6
2023
Q1
$6.8M Buy
4,500,000
+2,000,000
+80% +$3.02M 5.79% 6
2022
Q4
$6.25M Buy
+2,500,000
New +$6.25M 5.52% 7